WATCHMAN Left Atrial Appendage System for Embolic PROTECTion in Patients With Atrial Fibrillation

NCT00129545 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

800

Enrollment

INDUSTRY

Sponsor class

Conditions

Atrial Fibrillation
Stroke

Interventions

DEVICE: WATCHMAN Left Atrial Appendage Closure Technology
DRUG: Warfarin

Sponsor

Boston Scientific Corporation